ISSCA’s training assists hospital in developing better protocols for gynecological treatments
MIAMI LAKES, Florida—The International Society for Stem Cell Application, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, traveled to Guadalajara, Mexico in early February to collaborate with area physicians on how to utilize advancements in stem cell research and technology to find new solutions to health issues and concerns.
During ISSCA’s visit to Hospital Angeles del Carmen, physicians with the group partnered with Dr. Norma Patricia Ramos, director of the hospital’s gynecological department. During the two-day visit, ISSCA’s researchers and physicians provided valuable training and guidance on how stem cells can be used to develop better protocols for treating vaginal stenosis.
Vaginal stenosis is a condition that causes narrowing and/or loss of flexibility of the vagina and is a side effect of radiotherapy and/or genital surgery. It is often also accompanied by dryness and loss of resiliency of scar tissue.
The group reviewed new and effective treatment protocols available through stem cell therapies, including combining traditional CO2 laser treatments with stem cells harvested from adipose tissue.
The group also worked with Dr. Ramos and her team on new stem cell protocols to help women who have tried in vitro fertilization to get pregnant but have not experienced success due to a lack of ovarian reserves. The ISSCA group shared new research on the viability of utilizing stem cells from adipose tissue or bone marrow and reintegrating it into the ovaries using a laparoscopy with the goal of increasing ovarian reserves and increasing chances of pregnancy. Poor ovarian reserve (POR) is critical limiting factor for the success of any treatment modality for infertility, and new stem cell treatments provide a promising treatment protocol in increasing the quantity and quality of oocytes in women of reproductive age.
ISSCA is committed to partnering with physicians and researchers worldwide who have a vested interest in finding new solutions to improve treatments for any conditions. The group has an upcoming trip to Buenos Aires to partner with orthopedic doctors to discuss opportunities for stem cell therapies to improve treatment protocols in the field of orthopedics.
To learn more about ISSCA, visit https://www.issca.us/.
The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine. Their code of ethics emphasizes principles of morals and ethical conducts.
At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative
medicine and make it available to benefit patients both nationally and globally.
For more information, please visit https://www.issca.us/ or send an email to email@example.com